Advertisement
YOU ARE HERE: LAT HomeCollectionsBreast Cancer
IN THE NEWS

Breast Cancer

NEWS
February 2, 2012 | By Shari Roan, Los Angeles Times / For the Booster Shots blog
The long-debunked idea that abortions can contribute to breast cancer is reappearing amid the outpouring of comments this week on Susan G. Komen for the Cure's decision to stop funding Planned Parenthood breast-health programs. Here's one comment on Komen's Facebook page: "Also! Breast cancer is linked to abortions!!! More and more studied are pointing to abortions for a huge risk factor for BC, why should SGK support something that raises the chances of what they wasn't destroyed?
Advertisement
NEWS
October 28, 2010 | By Mary Forgione, Los Angeles Times
For many women, the fight against breast cancer is public, with support from friends and family and frequent discussions with healthcare professionals about side effects and treatment. But part of that fight is intensely private -- rarely more so than when it affects their sex life. Certain chemotherapy drugs send women into early menopause within a few months. That, coupled, with hair loss and disfiguring mastectomies, leave some breast cancer survivors struggling to be intimate again, a new study finds.
NEWS
January 6, 2012 | By Melissa Healy, Los Angeles Times/For the Booster Shots Blog
In a study suggesting that red wine might be the next big thing in breast cancer prevention, a study has found that women who drank just under two servings of red wine daily experienced hormonal changes that mimic the effects of a drug used to prevent malignant breast tumors from coming back. The study, published Friday in the Journal of Women's Health, found that consuming the same amount of white wine did not have the same effect in premenopausal women participating in the study.
NEWS
December 8, 2011 | By Eryn Brown, Los Angeles Times / For the Booster Shots blog
This post has been corrected. See note at bottom for details. Another reason to avoid the carbs: Researchers reported Thursday that increased carbohydrate intake was associated with a higher rate of breast cancer recurrence in survivors of the disease. Starch intake seemed to be particularly influential, they said, accounting for 48% of changes in the women's carbohydrate intake. "Women who increased their starch intake over one year were at a much likelier risk for recurring," team leader Jennifer Emond, a doctoral student in public health at UC San Diego, said in a statement.
NEWS
December 10, 2010 | By Shari Roan, Los Angeles Times
The breast cancer drug pertuzumab when added to Herceptin improved the treatment of women with early-stage, HER-2 positive breast cancer, researchers reported Friday at the annual meeting of the San Antonio Breast Cancer Symposium . Pertuzumab is an experimental monoclonal antibody. In the study, 417 women received monoclonal antibody drug therapy before having surgery to remove the tumor. Some women also underwent chemotherapy. Adding pertuzumab to Herceptin -- which is also known by the generic name trastuzumab -- along with the chemotherapy drug docetaxel led to a tumor eradication rate of 46%. That is 50% better than the tumor eradication rate achieved with the standard therapy of docetaxel and Herceptin combined, said the authors of the paper, from the National Cancer Institute in Milan, Italy.
NEWS
November 14, 2011 | By Karen Kaplan, Los Angeles Times / For the Booster Shots blog
Here's new evidence that the condition known as “chemo brain” is real: A study of breast cancer patients finds that women who had chemotherapy along with surgery to treat their disease had more trouble kicking their brains into high gear than women who were treated with surgery alone. They also performed much worse on tests of mental function than a group of healthy women who served as controls. The study , published Monday in Archives of Neurology, included 25 breast cancer survivors who had surgery and chemotherapy, 19 breast cancer survivors who had surgery but no chemotherapy, and 18 women with no history of breast cancer who were picked because their ages, level of education and menopausal status were similar to those of the women who had chemo.
NEWS
September 30, 2010 | Pregnant breast cancer patients more likely to survive
There may be few pregnancy nightmares worse than finding a lump in one's breast, given the dueling fears that if it's cancer, treatment could harm the developing fetus, while delay and pregnancy hormones could fuel a tumor's growth. But a new study finds that pregnant women treated for breast cancer are more likely to survive their ordeal than breast cancer patients of the same age who were not pregnant when their cancer was diagnosed. Five years after their diagnosis, almost 74% of the women diagnosed with breast cancer during pregnancy were still alive.
NEWS
November 28, 2012 | By Jon Bardin
A new genetic test may help determine whether a small tumor in the breast is likely to turn in to full-blown breast cancer, according to a study published Wednesday in the Journal of the National Cancer Institute. The small tumor, called a ductal carcinoma in-situ, or DCIS, resides in the milk ducts and is generally considered pre-cancerous. But according to the study, DCIS lesions left untreated will eventually progress to breast cancer in about 50% of patients. The lesions, which tend to be small and only detectable via mammogram, have become increasingly common as mammography has become more widespread.
Los Angeles Times Articles
|